Leukemia, Acute Myeloid disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
PDF) Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant - ScienceDirect
IJMS | Free Full-Text | Decoding the Phosphatase Code: Regulation of Cell Proliferation by Calcineurin
Acute myeloid leukemia: current progress and future directions | Blood Cancer Journal
Cancers | Free Full-Text | A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation
Obinutuzumab treatment in the elderly patient with chronic lymphocytic | CIA
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress | Nature Cancer
Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients. - Abstract - Europe PMC
Three years-Leukemia Free Survival of patients with AML/MDS with high... | Download Scientific Diagram
Acute myeloid leukemia: current progress and future directions | Blood Cancer Journal
Acute leukemia presenting as acute lower limb ischemia: Systematic review and case report: Vasa: Vol 51, No 1
Frontiers | Transcriptome profiling of osteoclast subsets associated with arthritis: A pathogenic role of CCR2hi osteoclast progenitors
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
Frontiers | Maintenance Therapy in AML
PDF) A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia: CIA Versus FIA in AML
Acute myeloid leukemia: current progress and future directions | Blood Cancer Journal
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study - The Lancet Haematology
Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia - ScienceDirect
Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody–Drug Conjugate Payloads | Journal of Medicinal Chemistry
Clofarabine for the treatment of adult acute myeloid leukemia | Future Oncology
Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients. - Abstract - Europe PMC
The incidence of CIA in different groups. | Download Table
Reference Protocol to Assess Analytical Performance of Higher Order Structural Analysis Measurements: Results from an Interlaboratory Comparison | Analytical Chemistry
Obinutuzumab treatment in the elderly patient with chronic lymphocytic | CIA
Phase I/II Study of Decitabine (DAC) followed by Clofarabine, Idarubicin, and Cytarabine (CIA) in Acute Leukemia 2012-1064
Current Oncology | Free Full-Text | Digital Innovation in Oncological Primary Treatment for Well-Being of Patients: Psychological Caring as Prompt for Enhancing Quality of Life
